In vivo saturation kinetics of two dopamine transporter probes measured using a small animal positron emission tomography scanner

被引:28
|
作者
Hume, SP
Brown, DJ
Ashworth, S
Hirani, E
Luthra, SK
Lammertsma, AA
机构
[1] PET Methodology Group, MRC Cyclotron Unit, Hammersmith Hospital, London W12 0NN, DuCane Road
[2] PET Centre, Free University Hospital, 1007 MB Amsterdam
关键词
positron emission tomography; rat; dopamine transporter; RTI-121; CFT;
D O I
10.1016/S0165-0270(97)00078-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
When estimated in vitro, the parameters which describe the binding of radiolabelled analogues of cocaine to sites on the dopamine transporter are very much influenced by the methodology used. In the present study, a small animal positron emission tomography (PET) scanner was used to estimate in vivo saturation kinetics for two carbon-11 labelled compounds presently used to monitor dopamine terminal function. The binding of [C-11]CFT (WIN 35,428) in rat striatum was adequately described by a single-site model, giving an apparent dissociation constant corresponding to an intravenous dose of 242 nmol/kg. In contrast, the binding of [C-11]RTI-121 was better described by a two-site model with the 'high-affinity' site or state (dissociation constant = 1 nmol/kg) being significantly occupied at doses routinely used in PET scanning. Such findings cannot readily be predicted from in vitro work, but could aid in both the choice of ligand and the model used in quantification of scan data. While multi-dose in vivo PET studies are difficult in man, rat PET can easily be employed either pre-clinically for putative radioligands, or experimentally, to study drug interactions and receptor occupancy related to functional efficacy. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:45 / 51
页数:7
相关论文
共 50 条
  • [1] In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography
    Learned-Coughlin, SM
    Bergström, M
    Savitcheva, I
    Ascher, J
    Schmith, VD
    Långstrom, B
    BIOLOGICAL PSYCHIATRY, 2003, 54 (08) : 800 - 805
  • [2] Quantitative analysis of dopamine D2 receptor kinetics with small animal positron emission tomography
    Nikolaus, S
    Beu, M
    Vosberg, H
    Müller, HW
    Larisch, R
    IMAGING IN BIOLOGICAL RESEARCH, PT A, 2004, 385 : 228 - 239
  • [3] Small animal Imaging using positron emission tomography
    Chatziioannou, AF
    NEUROTOXICOLOGY, 2003, 24 (02) : 287 - 288
  • [4] Small animal positron emission tomography imaging and in vivo studies of atherosclerosis
    Hag, Anne Mette Fisker
    Ripa, Rasmus Sejersten
    Pedersen, Sune Folke
    Bodholdt, Rasmus Poul
    Kjaer, Andreas
    CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, 2013, 33 (03) : 173 - 185
  • [5] In Vivo Evaluation of Limiting Brain Penetration of Probes for α2C-Adrenoceptor Using Small-Animal Positron Emission Tomography
    Kawamura, Kazunori
    Akiyama, Megumi
    Yui, Joji
    Yamasaki, Tomoteru
    Hatori, Akiko
    Kumata, Katsushi
    Wakizaka, Hidekatsu
    Takei, Makoto
    Nengaki, Nobuki
    Yanamoto, Kazuhiko
    Fukumura, Toshimitsu
    Zhang, Ming-Rong
    ACS CHEMICAL NEUROSCIENCE, 2010, 1 (07): : 520 - 528
  • [6] Metabolic activation of temozolomide measured in vivo using positron emission tomography
    Saleem, A
    Brown, GD
    Brady, F
    Aboagye, EO
    Osman, S
    Luthra, SK
    Ranicar, ASO
    Brock, CS
    Stevens, MFG
    Newlands, E
    Jones, T
    Price, P
    CANCER RESEARCH, 2003, 63 (10) : 2409 - 2415
  • [7] In vivo activity of modafinil on dopamine transporter measured with positron emission tomography and [18F]FE-PE2I
    Kim, WooChan
    Tateno, Amane
    Arakawa, Ryosuke
    Sakayori, Takeshi
    Ikeda, Yumiko
    Suzuki, Hidenori
    Okubo, Yoshiro
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 (05): : 697 - 703
  • [8] SEROTONERGIC MODULATION OF STRIATAL DOPAMINE MEASURED WITH POSITRON EMISSION TOMOGRAPHY (PET) AND IN-VIVO MICRODIALYSIS
    DEWEY, SL
    SMITH, GS
    LOGAN, J
    ALEXOFF, D
    DING, YS
    KING, P
    PAPPAS, N
    BRODIE, JD
    ASHBY, CR
    JOURNAL OF NEUROSCIENCE, 1995, 15 (01): : 821 - 829
  • [9] Prefrontal cortex dopamine release measured in vivo with positron emission tomography: Implications for the stimulant paradigm
    Hernaus, D.
    Mehta, M. A.
    NEUROIMAGE, 2016, 142 : 663 - 667
  • [10] Antiretroviral Tissue Kinetics: In Vivo Imaging Using Positron Emission Tomography
    Di Mascio, Michele
    Srinivasula, Sharat
    Bhattacharjee, Abesh
    Cheng, Lily
    Martiniova, Lucia
    Herscovitch, Peter
    Lertora, Juan
    Kiesewetter, Dale
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (10) : 4086 - 4095